Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Casali
P G
PG
Department of Cancer Medicine, Istituto Nazionale dei Tumori, Milan, Italy.
Blay
J-Y
JY
D000075369:Anoctamin-1; D001707:Biopsy, Needle; D018118:Chloride Channels; D003695:Delivery of Health Care / Q000592:standards*; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery*; D006801:Humans; D015994:Incidence; D010535:Laparoscopy; D008565:Membrane Proteins / Q000378:metabolism; D008938:Mitosis; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000378:metabolism; D009367:Neoplasm Staging; D019009:Proto-Oncogene Proteins c-kit / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics; D018570:Risk Assessment; D055502:Secondary Prevention; D016896:Treatment Outcome
C476213:ANO1 protein, human; D000075369:Anoctamin-1; D018118:Chloride Channels; D008565:Membrane Proteins; D009363:Neoplasm Proteins; D019009:Proto-Oncogene Proteins c-kit; D020796:Receptor, Platelet-Derived Growth Factor alpha